Aflibercept (Eylea, BAY86-5321) Clinical Trials
2 recruitingDrug
Showing 1–2 of 2 trials
Recruiting
Study to Learn More About Safety of Aflibercept Injection in Japanese Patients With Neovascular Glaucoma (NVG)
Neovascular Glaucoma
Bayer480 enrolled1 locationNCT04519619
Recruiting
A Study to Collect Data on the Use of Eylea in Babies Born Too Early Who Have a Condition of the Eye Where Blood Vessels Grow Abnormally in the Retina (Retinopathy of Prematurity)
Retinopathy of PrematurityInfantsNewborns
Bayer75 enrolled1 locationNCT05705258